”CTC provided us with excellent service during our phase 1 study in volunteers. CTC is flexible, service-minded and experienced.”– Jimmy Gu, ArkBio
“Asarina Pharma has used the PV and medical monitoring services from CTC. Everything has gone very smoothly, professionally and flexible; all the way from setting up the safety management plan to safety reporting and follow-ups. We would do it again!”— Märta Segerdahl, CMO, Asarina Pharma
“CTC’s recruitment team has done an absolutely fantastic job! In the middle of the corona pandemic’s most uncertain initial phase, we started a clinical study and enrollment is completed by a full month’s margin.”— Arvid Söderhäll,
CEO, Empros Pharma
“CTC is a close partner to IRL AB and we have used them for several of our studies. All studies have been managed with experienced and dedicated personnel along with high quality from start to study report.”— Joakim Tedroff, CMO, IRL
“CTC was innovative and found a complete e-solution in our study, using everything from electronic informed consent to full tele medicine visits over the internet with the physician. Working with CTC is inspiring.”— Kerstin Nilsson, CRM, BioGaia
“CTC provided us with excellent service during our FIH single ascending dose and multiple ascending dose study in volunteers and patients. CTC is flexible, service-minded and experienced.”— Thomas Edlund, CEO, Betagenon
“CTC has taken our product (monoclonal antibody) through the first time in human program all the way to Phase II. Leaving our studies in their hands is comfortable, in all aspects.”— Athera
”An immense thank you to the CTC Team and its partners for this extraordinary achievement during the COVID pandemic. Special congratulations for:– Karine Renard, JTI
– The PI and Site staff for their tremendous performance with high quality deliver,
– The Project Lead for her proactivity, risk-based approach, problem solving sprit and the outstanding coordination of all actors around our project to meet milestones on time
– The entire project Team for huge professionalism and resilience in finding the best solutions to achieve successful project resolution and completion.
High delivery with highly experienced, professional and dedicated people!”
Our pipeline consists of several candidate drugs in clinical and late preclinical development, and as a lean organization, we rely on close and effective collaborations with external partners to ensure high standards, scalability and a cost-effective development. CTC, having both scientific and operational expertise, is an ideal and highly valued partner to us.– Elin Rosendahl, VP Clinical Development at Vicore Pharma, a Swedish clinical-stage pharmaceutical company publicly listed on Nasdaq Stockholm
A safe and efficient advancement of candidate drugs from preclinical to initial human testing requires broad scientific knowledge, thorough operational planning and a high level of flexibility. In our collaborations, the CTC team has showed that it is possible to build in both adaptive design elements and early exploration of efficacy signals in first-in-human (FiH) protocols while maintaining a focus on trial participant safety. Effective operations and a customer-focused mindset have, together with the adaptive design elements, made the trial conduct smooth and successful.
From both a scientific and operational perspective, I would highly recommend CTC as a preferred partner for FiH and other human pharmacology trials.